<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rao S</submitter><funding>NCI NIH HHS</funding><pagination>100873</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12935155</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Although statistical models have been commonly used to identify patients at risk of cardiovascular disease for preventive therapy, these models tend to over-recommend therapy. Moreover, in populations with pre-existing diseases, the current approach is to indiscriminately treat all, as modelling in this context is currently inadequate. This study aimed to develop and validate the Transformer-based Risk assessment survival (TRisk) model, a novel deep learning model, for predicting 10-year risk of cardiovascular disease in both the primary prevention population and individuals with diabetes.&lt;h4>Methods&lt;/h4>An open cohort of 3 million adults aged 25-84 years was identified using linked electronic health records from 291 general practices, for model development, and 98 gener</pubmed_abstract><journal>The Lancet. Digital health</journal><pubmed_title>Refined selection of individuals for preventive cardiovascular disease treatment with a transformer-based risk model.</pubmed_title><pmcid>PMC12935155</pmcid><funding_grant_id>P30 CA008748</funding_grant_id><pubmed_authors>Vickers A</pubmed_authors><pubmed_authors>Salimi-Khorshidi G</pubmed_authors><pubmed_authors>Rao S</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Yau C</pubmed_authors><pubmed_authors>Wamil M</pubmed_authors><pubmed_authors>Jackson R</pubmed_authors><pubmed_authors>Mamouei M</pubmed_authors><pubmed_authors>Rahimi K</pubmed_authors><pubmed_authors>Danaei G</pubmed_authors><pubmed_authors>Nazarzadeh M</pubmed_authors><pubmed_authors>Collins GS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Refined selection of individuals for preventive cardiovascular disease treatment with a transformer-based risk model.</name><description>&lt;h4>Background&lt;/h4>Although statistical models have been commonly used to identify patients at risk of cardiovascular disease for preventive therapy, these models tend to over-recommend therapy. Moreover, in populations with pre-existing diseases, the current approach is to indiscriminately treat all, as modelling in this context is currently inadequate. This study aimed to develop and validate the Transformer-based Risk assessment survival (TRisk) model, a novel deep learning model, for predicting 10-year risk of cardiovascular disease in both the primary prevention population and individuals with diabetes.&lt;h4>Methods&lt;/h4>An open cohort of 3 million adults aged 25-84 years was identified using linked electronic health records from 291 general practices, for model development, and 98 gener</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-07-16T20:44:24.948Z</modification><creation>2026-07-10T03:11:16.03Z</creation></dates><accession>S-EPMC12935155</accession><cross_references><pubmed>40461349</pubmed><doi>10.1016/j.landig.2025.03.005</doi></cross_references></HashMap>